Avaneer Health is a brand-new business focused on making it easier, faster and more cost-effective for the health care industry to exchange data. Consider this “disruption from the inside-out” – Avaneer is founded and backed by a consortium of top industry heavyweights including Aetna, Anthem, Cigna, Cleveland Clinic, HCSC, IBM, The PNC Financial Services Group, Inc. and Sentara Healthcare.

Hear from CEO, Stuart Hanson:

• “Do We Need a New Tech Layer?” on Thursday, September 9 at 1:15PM Eastern

Check out Avaneer’s Sponsored Session:

Time to Stop Doing the Same and Expecting Different Results: How Healthcare Stakeholders Can Work Together to Make Interoperability Finally Happen
Wednesday September 8 at 11:30AM Eastern & Thursday, September 9 at 10.30AM Eastern

Healthcare has been trying to solve the interoperability puzzle with the same tools and tricks. But data silos, disconnected systems, and a spaghetti bowl of expensive connections remain. It’s time to do something different and borrow from what Verizon and Zelle have done and create a healthcare network with secure endpoints. In this session, payers and providers describe why they have chosen “coopetition” to bring together a solution that will finally make interoperability happen.

Panel:

• Addison McGuffin, Digital and Innovation Officer, HCSC
  
• Sonja O’Malley, Senior Director, Innovation, Cleveland Clinic
  
• Tim Skeen, Senior Corporate Vice President and Chief Information Officer, Sentara
  
• Mary Butler-Everson, SVP, Healthcare Product Innovation, PNC (moderator)

THE marketing agency for health tech’s most disruptive businesses, 120/80 is famous for smart PR strategy, healthcare marketing expertise, and the out-of-the-box thinking it takes to turn health care execs into innovation thought leaders. From fundraising news to IPO glory, or knowing how to curate socially relevant discussions about top issues like gender parity in health care leadership or health equity in mental health care, 120/80’s client list boasts some of the biggest-names and hottest startups in the business.

Check out 120/80’s Sponsored Session:

Optimizing Clinical Care Delivery For The Underserved: Unpacking Innovative Care Models For Medicaid Populations
Thursday, September 9 at 11.30AM Eastern & Friday, September 10 at 10:30AM Eastern

Panel:

• Dr. Jon Kole, Head of Psychiatry, Ginger
  
• Anna Lindow, CEO, Brave Health
  
• Toyin Ajayi, President & Co-founder, Cityblock Health
  
• Vik Bakru, Chief Medical Officer & Head of Mosaic, Circulo
  
• Moderator: Solome Tibebu, Behavioral Health Strategist & Investor

Cloud API developer, Skyflow, is the first to bring health tech the “Healthcare Data Privacy Vault,” the first zero trust data vault designed specifically for personal health information (PHI). The new vault is delivered as a cloud API and its customizable data schema supports the “HIPAA 18”—the 18 regulated data types specifically identified by the law—out of the box, allowing health tech software teams to innovate more rapidly without worrying about patient privacy, data security, or HIPAA and other regulatory concerns. Development teams can build a Skyflow vault into their apps at the data layer in the manner of a couple hours and it can fit into any architecture, including legacy systems.

Check out Skyflow’s Sponsored Session:

New Approaches to Healthcare Data Privacy
Friday, September 10 at 11:30AM Eastern

The challenges of data privacy, security, and regulatory compliance are multiplying at the same time the need to get innovative digital solutions in the hands of patients, practitioners and administrators is increasing. Join Anshu Sharma, CEO/Co-founder of Skyflow; Fawad Butt, former Chief Data Officer of United Healthcare and Executive in Residence at Canvas Ventures; and Brian Greene, CTO/Co-founder of HMD Labs and former Cloud Data Architect at Auris Surgical in this practical panel discussion centered on the latest ideas, architectures, and best practices for handling healthcare data privacy without hindering healthcare innovation.

Panel:

• Fawad Butt, former Chief Data Officer of United Healthcare and Optum & Executive in Residence at Canvas Ventures
  
• Brian Greene, co-founder & Chief Technology Officer, HMD Labs
  
• Anshu Sharma, co-founder & CEO, Skyflow

As big a name in telehealth as you can get, Amwell is a global leader in digital care delivery. Its single, comprehensive platform is built to support all telehealth needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. Amwell provides the “infrastructure” for digital care delivery for more than 2,000 hospitals and 55 health plans, and its services are accessible to over 80 million people around the world.

Two chances to hear from Amwell’s CEO, Roy Schoenberg:

• “Are Telehealth Companies Infrastructure or Care Delivery?” on Thursday, September 9 at 4PM Eastern
  
• “Drinking Judy Faulkner’s Milkshake? Who’s Rebuilding Health’s IT Infrastructure?”

Check out Amwell’s Sponsored Session:

Building the Infrastructure of Digital Care: Amwell, Conversa Health & SilverCloud Health
Wednesday September 8 at 11:00AM Eastern

Amwell recently shook up the market with its acquisitions of Conversa Health and SilverCloud Health. Now the CEOs of Amwell, Conversa and SilverCloud are sitting down with Jessica DaMassa for their first joint interview to discuss their plans for reimagining the future of healthcare and the collective impact they will have as together they strengthen the cohesion between physical, automated and virtual care.

Panel:

• Ido Schoenberg, Chairman & co-CEO, Amwell
  
• Murray Brozinsky, CEO, Conversa Health
  
• Ken Cahill, CEO, SilverCloud Health
  
• Moderator: Jessica DaMassa, Executive Producer & Host, WTF Health

In the chronic condition management space, Lark stands out among digital health competitors for its tech-first approach, using conversational AI to handle nearly all interventions with text messaging. The scalability and cost-effectiveness of “machine-first” diabetes care, diabetes prevention, and hypertension care programs has caught the eye of some of the largest health plans in the US and Lark’s Diabetes Prevention Program, known for being one of the lowest cost DPPs out there, has received CDC Full Recognition.

Catch Lark’s CEO Julia Hu:

• “Human versus Machine: What’s Going to Work in Chronic Care” on September 10 at 2:45PM Eastern

Check out Lark’s Sponsored Session:

Can Virtual Care Really Work for Everyone?
Thursday September 9 at 11AM Eastern

As we look toward a future of health care that relies on more virtual care delivery, how can we make sure every patient has access to and can benefit from these new technologies? Executives from virtual care companies will discuss strategies to ensure that digital health solutions are easy-to-use, accessible, and effective for all populations, including older adults and those without access to broadband. The session will also discuss how digital solutions can help eliminate existing biases in health care, rather than amplify them. A deeper dive on the panel “Human vs. Machine: What’s Going to Work in Chronic Care?” this breakout session will focus on how to ensure “machine”-driven care remains compassionate, personalized, and engaging — for all populations.

Panel:

• Julia Hu, CEO, Lark
  
• Simon MacGibbon, CEO, Myia Health
  
• Jon Bloom, CEO, Podimetrics
  
• Dr. Brad Younggren, Chief Medical Officer, 98.6
  
• Jonah Comstock, Editor in Chief at HIMSS Media

While we may keep trying to put Transcarent into the “healthcare navigator” box or call it a “second opinion service” or a “centers of excellence play,” the truth is that those are all means to achieve a much larger end: redefine the health care experience and its payment model for self-insured employers. Transcarent is on a mission to boldly cut down the cost of care, partnering with employers and going at-risk to negotiate better terms for everything from surgery to prescription drug plans for their employees. Not that we need to even mention it, but this is health-tech-legend Glen Tullman’s new business – and it’s scaling up at a pace that’s even faster than what we saw at Livongo.

Catch CEO Glen Tullman:

• Keynote Fireside Chat at 3:15PM Eastern on September 8
  
• “How Did We Get Here, and Can Navigators Plot Our Way Out?” at 3:45PM Eastern on September 8

Aetion is using real world data (any data outside of clinical trial data) to help the manufacturers, purchasers, and regulators of medical treatments and technologies gain deeper insight into how their products impact people. This is next-gen health outcomes research bringing data from the everyday world (and an expanded population of people) into the way health care and life sciences businesses develop products.

Aetion’s CEO Carolyn Magill joins us:

• “Oh, Go Jump in the Data Lake: Are We Able to Finally Extract Value from Massive Health Data Sets?” on September 10 at 4.15PM Eastern

National primary care clinic, Crossover Health, got health tech famous as Amazon’s choice for its employees’ care. With an “omnichannel model” that blends in-person, virtual, and asynchronous care, the national medical group is scaling and prides itself on its multidisciplinary team approach and its bundled, flat-fee payment model that’s extra appealing to employers.

Crossover Health’s CEO Scott Shreeve joins us:

• “What’s the Future of Primary Care? Retail vs Concierge Medicine vs At-Risk” on September 8 at 1PM Eastern

Merck Global Health Innovation Fund (Merck GHI) has $500M under management and provides growth capital to emerging healthcare technology companies worldwide while leveraging the vast R&D-based, global resources of Merck. With a vision that data will be the currency in healthcare, GHI invests broadly in digital health. GHI invests in platform companies with proven technologies or business models where Merck’s expertise and perspectives can accelerate revenue growth and enhance value creation. Since late 2010, Merck GHI has made over 20 investments in Digital Health companies.

Hear from Merck GHIF’s President, Bill Taranto:

• How Much are these Companies Really Worth? The IPO & SPAC Panel on September 10 at 1pm Eastern

Check out Merck GHIF’s Sponsored Session:

Infectious Disease Telehealth and ID Technologies in a Post Pandemic World
Wednesday September 8 at 10:30am ET

Panel:

• Dave Zynn, President & CEO of Infectious Disease Connect (IDC)
  
• Erin K. McCreary, PharmD, BCPS, BCIDP, Director of Stewardship Innovation, Infectious Disease Connect and UPMC Clinical Assistant Professor of Medicine, University of Pittsburgh
  
• Dr. Marc Scheetz. Professor and Director of Pharmacometrics Center of Excellence at Midwestern University (IL)
  
• Moderator: Joel Krikston, Managing Director Venture Investments and Head of Strategic Innovation Alliances, Merck Global Health Innovation Fund

Earlier this year, Newtopia launched a new category of healthcare provider, the Habit Change Provider, in effort to more accurately describe the role of companies working to change the way people behave in their everyday lives. Newtopia’s been in this business for over a decade, starting its path to commercialization with Aetna and a three-year randomized control trial of more than 2,800 Aetna employees that proved the power of prevention: physical risk reduction, clinical cost savings, and the “holy grail” of any population health model, in-year ROI.

See Newtopia’s CEO Jeff Ruby:

• “Do We Really Need to Integrate Mental and Physical Care?” on September 9 at 3.15PM Eastern

Zus is creating the industry’s first shared development platform, providing a developer kit of components common to the “middle” of a health tech stack — AND a single shared record backend where all Zus clients can land and access patient data. The intention is to help digital health startups reduce the time and cost of developing their tech by eliminating the redundant, generic aspects of building a healthcare tech stack in the same way companies like Stripe or Twilio have taken the burden out of writing code to process payments or integrate messaging.

Catch Zus’s CEO Jonathan Bush:

• Keynote address on September 9 at 12:55pm Eastern
  
• “Do We Need A New Tech Layer?” on Thursday, September 9 at 1:15PM Eastern
  
• “Drinking Judy Faulkner’s Milkshake? Who’s Rebuilding Health’s IT Infrastructure?”

Check out Newtopia’s Sponsored Session:

There’s Not Always an App for That
Friday September 10 at 11AM Eastern

While technology is viewed as a cure for many ills, it remains true that human-to-human interaction is most effective for long-lasting behavior change. This panel discussion will focus on how payers and employers leverage the power of habit change and 1:1 health coaching to achieve real, lasting outcomes, that grow over time. This session will discuss recent evidence-based outcomes.

Panel:

• Lara Dodo, Chief Growth & Operating Officer, Newtopia
  
• Nancy Cocozza, former President, Medicare Business, Aetna
  
• Ian Duncan, PhD FSA MAAA, Santa Barbara Actuaries